Target intelligence / Profile preview

Physiological iron-binding proteins

Molecular classification
Transport protein, Storage protein, Metalloprotein, Other
01

Overview

Physiological iron-binding proteins are a specialized group of proteins, including transferrin, ferritin, and lactoferrin, that regulate the acquisition, transport, and storage of iron in the body [1][2]. Transferrin serves as the primary vehicle for iron transport in the plasma, while ferritin provides a safe intracellular shell for iron storage, preventing the formation of toxic hydroxyl radicals via the Fenton reaction [2][3]. These proteins are essential for maintaining iron homeostasis, which is critical for erythropoiesis, DNA synthesis, and cellular respiration [3]. In clinical medicine, these proteins are the focus of treatments for iron-related disorders; for instance, iron chelators like deferoxamine are used to treat systemic iron overload by binding to iron and facilitating its removal [4]. Conversely, iron deficiency is managed by providing exogenous iron to saturate these binding proteins and restore physiological levels [1]. Beyond metabolism, proteins like lactoferrin contribute to the innate immune system by sequestering iron from microbes, thereby inhibiting their growth [5].

Other names
Iron-binding proteinsIron-sequestration proteinsSiderophilinsIron transport and storage proteins
02

Mechanism of action

Iron chelators (e.g., deferoxamine) bind to ferric iron with high affinity to form stable complexes that are excreted, thereby reducing systemic iron load [4]. Iron supplements provide elemental iron that is incorporated into these binding proteins to support erythropoiesis and cellular function [1][3].

03

Biological functions

Iron homeostasisOxygen transportRedox regulationInnate immunityCellular respiration
04

Disease associations

Iron deficiency anemiaHereditary hemochromatosisAnemia of chronic diseaseNeurodegenerative diseaseInfection
05

Safety considerations

Risk of iron toxicity and oxidative stressHypersensitivity to parenteral ironGastrointestinal intolerance to oral ironOrgan damage from chronic iron deposition
06

Interacting drugs

Deferoxamine

6 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)Total iron-binding capacity (TIBC)Soluble transferrin receptor (sTfR)

Beyond the preview

Go deeper on Physiological iron-binding proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological iron-binding proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call